Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC

BACKGROUND: Chimeric antigen receptor (CAR)-T cells can induce powerful immune responses in patients with hematological malignancies but have had limited success against solid tumors. This is in part due to the immunosuppressive tumor microenvironment (TME) which limits the activity of tumor-infiltr...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrasser, Micaela, Gohil, Satyen Harish, Lau, Hiu, Della Peruta, Marco, Muczynski, Vincent, Patel, Dominic, Miranda, Elena, Grigoriadis, Kristiana, Grigoriadis, Anita, Granger, David, Evans, Rachel, Nathwani, Amit Chunilal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166313/
https://www.ncbi.nlm.nih.gov/pubmed/35659040
http://dx.doi.org/10.1186/s13058-022-01531-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166313/
https://www.ncbi.nlm.nih.gov/pubmed/35659040
http://dx.doi.org/10.1186/s13058-022-01531-1

Ejemplares similares